FDA Inspection 1153395 — Bayer Healthcare Pharmaceuticals Inc.
The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on Sep 15, 2021 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Whippany, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)